Age, Biography and Wiki
Janet Hemingway was born on 13 June, 1957 in West Yorkshire, is a British infectious diseases specialist. Discover Janet Hemingway's Biography, Age, Height, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is she in this year and how she spends money? Also learn how she earned most of networth at the age of 66 years old?
| Popular As |
N/A |
| Occupation |
N/A |
| Age |
66 years old |
| Zodiac Sign |
Gemini |
| Born |
13 June 1957 |
| Birthday |
13 June |
| Birthplace |
West Yorkshire |
| Nationality |
United Kingdom
|
We recommend you to check the complete list of Famous People born on 13 June.
She is a member of famous with the age 66 years old group.
Janet Hemingway Height, Weight & Measurements
At 66 years old, Janet Hemingway height not available right now. We will update Janet Hemingway's Height, weight, Body Measurements, Eye Color, Hair Color, Shoe & Dress size soon as possible.
| Physical Status |
| Height |
Not Available |
| Weight |
Not Available |
| Body Measurements |
Not Available |
| Eye Color |
Not Available |
| Hair Color |
Not Available |
Dating & Relationship status
She is currently single. She is not dating anyone. We don't have much information about She's past relationship and any previous engaged. According to our Database, She has no children.
| Family |
| Parents |
Not Available |
| Husband |
Not Available |
| Sibling |
Not Available |
| Children |
Not Available |
Janet Hemingway Net Worth
Her net worth has been growing significantly in 2023-2024. So, how much is Janet Hemingway worth at the age of 66 years old? Janet Hemingway’s income source is mostly from being a successful . She is from United Kingdom. We have estimated Janet Hemingway's net worth, money, salary, income, and assets.
| Net Worth in 2024 |
$1 Million - $5 Million |
| Salary in 2024 |
Under Review |
| Net Worth in 2023 |
Pending |
| Salary in 2023 |
Under Review |
| House |
Not Available |
| Cars |
Not Available |
| Source of Income |
|
Janet Hemingway Social Network
Timeline
Janet Hemingway (born 1957) is a British infectious diseases specialist.
She is the former Director of Liverpool School of Tropical Medicine (LSTM) and founding Director of Infection Innovation Consortium and Professor of Tropical Medicine at LSTM.
She is current President of the Royal Society of Tropical Medicine and Hygiene.
Hemingway was born in a small mining town in West Yorkshire in 1957 to parents who owned a corner shop.
She obtained a first-class honours degree in zoology and genetics from the University of Sheffield, where she set up the university's first Mosquito insectary as part of her thesis project.
She was invited to pursue a PhD at the London School of Hygiene and Tropical Medicine (LSHTM), and within two years had obtained her doctorate on the biochemistry and genetics of insecticide resistance in Anopheles mosquitoes.
Hemingway has over 30 years of experience working on the biochemistry and molecular biology of specific enzyme systems associated with xenobiotic resistance, most notably the malaria-transmitting Mosquito.
Hemingway is distinguished as the international authority on insecticide resistance in insect vectors of disease.
She was first to report co-amplification of multiple genes on a single amplicon and demonstrate their impact on disease transmission.
Her studies on resistance management have transformed the use of insecticide by disease control programmes.
Her promotion of evidence-based monitoring and evaluation strategies for insecticide resistance has guided and improved international policy on vector control strategies for Onchocerciasis, Malaria, and other vector borne diseases.
Her rigorous scientific approach to resistance analysis has contributed to a greater understanding of resistance, its impact and spread and has minimised its effect in increasing human mortality and morbidity.
While serving as Director of LSTM between 2001 and 2019, Hemingway oversaw a period of organisational growth.
This included the awarding of Higher Education Institution Status & Degree Awarding powers to LSTM.
For her 2012 contributions to the Prevention of Tropical Disease Vectors, she received the Commander of the British Empire (CBE).
She assumed the role of founding director of iiCON in 2020.
iiCON is a collaborative R&D initiative creating a premier international center for infectious disease R&D in the North West of England.
Hemingway also works on advocacy and resource mobilisation (and was previously chief executive officer) at the Innovative Vector Control Consortium (IVCC) (funded by the Bill and Melinda Gates Foundation), and is International Director of the Joint Centre for Infectious Diseases Research, Jizan, Saudi Arabia.
